EVEREST
DEAD

Serial Number

88584518

Owner

EverNov Medicines Limited

Attorney

David Devernoe

Filing Date

Aug 19, 2019

Add to watchlist:

No watchlists yet
View on USPTO

EVEREST Trademark

Serial Number: 88584518

EVEREST is a trademark filed by EverNov Medicines Limited on August 19, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

EverNov Medicines Limited (3 trademarks)

West Nanjing 1266
Shanghai 200040 , CN

Entity Type: 16

Trademark Details

Filing Date

August 19, 2019

Registration Date

Not Registered

Published for Opposition

September 22, 2020

Goods & Services

Pharmaceuticals, namely, pharmaceutical preparations for treating diseases and conditions in the field of oncology/hematology, immunology, cardiology, renal diseases, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory diseases, metabolic diseases, dermatology, and gastrointestinal or women's health; pharmaceutical drugs, namely, pharmaceutical preparations for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, and gastrointestinal or women's health; pharmaceutical preparations for health care, namely, for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, and gastrointestinal or women's health; pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in connection with humans for oncology/hematology, immunology, cardiology, renal diseases, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory diseases, metabolic diseases, dermatology, and gastrointestinal or women's health

Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; chemical substances for use in the production of drugs

Filing History

ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Nov 30, 2020 MAB5
ABANDONMENT - AFTER PUBLICATION
Nov 30, 2020 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Nov 24, 2020 EXAR
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 22, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 22, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 22, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 2, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 18, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 17, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 17, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 3, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 3, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 3, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 13, 2020 CRFA
ASSIGNED TO LIE
Jul 6, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 24, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2020 CNRT
ASSIGNED TO EXAMINER
May 20, 2020 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 20, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 20, 2019 GNRT
NON-FINAL ACTION WRITTEN
Nov 20, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 18, 2019 DOCK
LETTER OF PROTEST EVIDENCE FORWARDED
Oct 16, 2019 LOPT
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2019 NWOS
NEW APPLICATION ENTERED
Aug 22, 2019 NWAP